An interesting study was presented by Watts et al. [29] (Chandigarh, India), who investigated the use of 68Ga-pentixafor PET/CT, targeting the chemokine receptor CXCR4, in 25 lung cancer patients. This evidence concerns the gene CXCR4 and lung carcinoma.